Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.52 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.46 |
| ▸ | PRKCG | P05129 | 1/20 | 0.46 |
| ▸ | PRKCB | P05771 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | PRKCH | P24723 | 1/20 | 0.46 |
| ▸ | PRKCI | P41743 | 1/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.46 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.46 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1070338 | 1.00 | USP2 (0.53) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL13286559 | 0.92 | TDP1 (0.48) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL25847365 | 0.91 | TDP1 (0.43) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL13286582 | 0.90 | USP2 (0.46) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL11436004 | 0.89 | LPAR1 (0.52) | LPAR1LPAR3 | |
| SCHEMBL26912037 | 0.87 | USP2 (0.43) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL7243087 | 0.86 | TSHR (0.44) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL8644294 | 0.84 | USP2 (0.52) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL16338301 | 0.84 | USP2 (0.52) | USP2HTTSPHK1PRKD3PRKCG | |
| SCHEMBL13966880 | 0.84 | USP2 (0.52) | USP2HTTSPHK1PRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3003718-B1 | SUCCESSIVELY PEELABLE COEXTRUDED POLYMER FILM WITH EMBEDDED ANTIMICROBIAL LAYER(S) | 3M INNOVATIVE PROPERTIES CO (US) | 2021-12-29 | — | — | EP | disclosed |
| EP-3905985-A1 | ANTIMICROBIAL DENTAL APPLIANCE | 3M Innovative Properties Company (US) | 2021-11-10 | — | — | EP | disclosed |
| US-10918618-B2 | Methods of reducing microbial contamination | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-02-16 | — | — | US | disclosed |
| WO-2020141444-A1 | ANTIMICROBIAL DENTAL APPLIANCE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-07-09 | — | — | WO | disclosed |
| US-10682830-B2 | Successively peelable coextruded polymer film with embedded antimicrobial layer(s) | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-06-16 | — | — | US | disclosed |
| US-20200030276-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-01-30 | — | — | US | disclosed |
| US-10471036-B2 | Antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-12 | — | — | US | disclosed |
| EP-2497459-B1 | Methods of reducing microbial contamination | 3M INNOVATIVE PROPERTIES CO (US) | 2019-04-24 | — | — | EP | disclosed |
| EP-3025704-B1 | METHODS OF REDUCING MICROBIAL CONTAMINATION | 3M INNOVATIVE PROPERTIES CO (US) | 2019-01-16 | — | — | EP | disclosed |
| CN-108853607-A | A kind of insulin needle surface siliconization inorganic agent | 广州市爱创医疗科技有限公司 | 2018-11-23 | — | — | CN | disclosed |
| EP-1672989-A1 | CONCENTRATED ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M Innovative Properties Company (US) | 2006-06-28 | — | — | EP | disclosed |
| EP-1673062-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M Innovative Properties Company (US) | 2006-06-28 | — | — | EP | disclosed |
| EP-1662873-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M Innovative Properties Company (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20050089539-A1 | Antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-04-28 | — | — | US | disclosed |
| US-20050084471-A1 | Concentrated antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-04-21 | — | — | US | disclosed |
| US-20050058673-A1 | Antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-03-17 | — | — | US | disclosed |
| WO-2005023023-A1 | CONCENTRATED ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005022998-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005023233-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-17 | — | — | WO | disclosed |
| US-20050053593-A1 | Antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10918618-B2 | Methods of reducing microbial contamination | LPO, CAT, UNG | USP2 191/4885HTT 1517/4885SPHK1 1766/4885 |
| US-20050084471-A1 | Concentrated antimicrobial compositions and methods | SHARPIN, PIK3C3, SRM | USP2 897/4885HTT 1158/4885SPHK1 1244/4885 |
| US-10682830-B2 | Successively peelable coextruded polymer film with embedded antimicrobial layer(s) | PUF60, PCBP1, CD99 | USP2 701/4885HTT 2949/4885SPHK1 4515/4885 |
| US-20200030276-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS | FABP2, CUTA, LIPA | USP2 3907/4885HTT 4409/4885SPHK1 455/4885 |
| US-20050089539-A1 | Antimicrobial compositions and methods | FABP2, CUTA, LIPA | USP2 3907/4885HTT 4409/4885SPHK1 455/4885 |
| US-10471036-B2 | Antimicrobial compositions and methods | FABP2, CUTA, LIPA | USP2 3907/4885HTT 4409/4885SPHK1 455/4885 |
| US-20050058673-A1 | Antimicrobial compositions and methods | FABP2, CUTA, LIPA | USP2 4068/4885HTT 4413/4885SPHK1 670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.